PDE10A and central nervous system disorder: Since many drugs used in neuropsychiatry alter DAneurotransmission, PDE10A binding quantified by PET imaging in CNS disorders may bebiased by treatment with dopaminergic drugs Activation of theD1 over the D2 receptor pathway isresponsible for the effects of chronic D-amphetamine exposure.